| CCNH |
CCNH: Cyclin-H |
CDC2 |
CDC2: Cell division control protein 2 homolog |
17.690 |
Evidence |
O
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
17.690 |
Evidence |
O
|
| RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
17.430 |
Evidence |
O
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
17.210 |
Evidence |
O
|
| RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
17.090 |
Evidence |
O
|
| RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
TNPO1 |
|
17.080 |
Evidence |
O
|
| EIF5B |
EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B |
EIF1AX |
EIF1AX, EIF1A, EIF4C: Eukaryotic translation initiation factor 1A, X-chromosomal |
17.080 |
Evidence |
O
|
| MCM5 |
MCM5, CDC46: DNA replication licensing factor MCM5 |
ORC1L |
ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 |
17.050 |
Evidence |
O
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CKS2 |
CKS2: Cyclin-dependent kinases regulatory subunit 2 |
16.940 |
Evidence |
O
|
| ARPC2 |
ARPC2, ARC34, PRO2446: Actin-related protein 2/3 complex subunit 2 |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
16.940 |
Evidence |
O
|
| GNG7 |
GNG7, GNGT7: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 p |
GNB3 |
GNB3: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 |
16.940 |
Evidence |
O
|
| EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
16.870 |
Evidence |
O
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
16.670 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
16.570 |
Evidence |
O
|
| EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
SKIV2L |
SKIV2L, XXbac-BCX116I9.5-001, XXbac-BPG116M5.1-001: Superkiller viralicidic acti |
16.570 |
Evidence |
O
|
| HCK |
IPI00029769 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
16.420 |
Evidence |
O
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
16.390 |
Evidence |
O
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
16.290 |
Evidence |
O
|
| SF3A2 |
SF3A2, SAP62: Splicing factor 3A subunit 2 |
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
16.190 |
Evidence |
O
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
16.110 |
Evidence |
O
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MYOG |
MYOG, MYF4: Myogenin |
15.840 |
Evidence |
O
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
15.840 |
Evidence |
O
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
15.760 |
Evidence |
O
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
15.760 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
15.760 |
Evidence |
O
|
-